AstraZeneca launches digital products, services business


AstraZeneca launched Evinova. Evinova is offering globally-scaled digital products and services to the life sciences and healthcare as artificial intelligence (AI) moves into the mainstream.

AstraZeneca is based in Cambridge, UK, with a U.S. headquarters, logistics and packaging operation in northern Delaware. At last report, the company employs 1,500 in Delaware.

Evinova will place a priority on market established digital technology solutions already being used globally by AstraZeneca for clinical trial design and delivery. The goal is reduce the time and cost of developing new medicines, bring care closer to home for patients and reduce the burden on health systems. Evinova will also pursue opportunities in digital remote patient monitoring and digital therapeutics with a pipeline of digital advances, a release stated.

Pascal Soriot, CEO of AstraZeneca, said: “The future of medicine development can be accelerated with digital solutions. We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.”

Cristina Duran, president of Evinova, said: “We are excited to bring the portfolio of globally-scaled digital solutions developed to serve AstraZeneca’s drug development pipeline to the wider life sciences community. We believe this will help propel the sector forward in digital health, as we know healthcare professionals and regulators need digital solutions that work across pharma and support patients broadly. Coming from within the sector and with proven experience, Evinova will be uniquely placed to deliver science-based, evidence-led and human experience-driven solutions with the aim of improving patient experience and outcomes.” Duran is based at AstraZeneca’s Cambridge headquarters.


Tech companies Parexel and Fortrea have entered into agreements to offer Evinova digital health solutions to their customer base. To accelerate industry adoption and sustain and expand the global reach of its digital products, Evinova is collaborating with Accenture and Amazon Web Services.

Evinova will combine clinical and regulatory experience gained at AstraZeneca with its expertise in digital technology spanning strategy and development, digital product development, data science and AI, user experience design and bahavioral science. In addition to digital solutions, Evinova will offer custom scientific solutions, including remote patient monitoring and endpoint solutions, as well as trial design and consulting services.

Pharma companies are working to find ways to reduce the cost and high failure rate of research efforts, partly the result of more easily discovered drugs already in the marketplace. AI promises to increase the odds of finding breakthroughs.